The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry from politicians on all sides. Even President Emmanuel Macron ...
The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry against the project from politicians on all sides. Even President ...